Correlation Between Purple Biotech and Champions Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Champions Oncology, you can compare the effects of market volatilities on Purple Biotech and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Champions Oncology.

Diversification Opportunities for Purple Biotech and Champions Oncology

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between Purple and Champions is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Purple Biotech i.e., Purple Biotech and Champions Oncology go up and down completely randomly.

Pair Corralation between Purple Biotech and Champions Oncology

Given the investment horizon of 90 days Purple Biotech is expected to under-perform the Champions Oncology. In addition to that, Purple Biotech is 2.22 times more volatile than Champions Oncology. It trades about -0.03 of its total potential returns per unit of risk. Champions Oncology is currently generating about 0.08 per unit of volatility. If you would invest  398.00  in Champions Oncology on August 28, 2024 and sell it today you would earn a total of  20.00  from holding Champions Oncology or generate 5.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Purple Biotech  vs.  Champions Oncology

 Performance 
       Timeline  
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Champions Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Champions Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Champions Oncology is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Purple Biotech and Champions Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Purple Biotech and Champions Oncology

The main advantage of trading using opposite Purple Biotech and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.
The idea behind Purple Biotech and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories